HealthyWay Unveils Full-Link Compliance Solution at MMC Medical Marketing Annual Conference and Wins "Best Innovative Service Partner" Award
On August 26, the 11th SQi Circle MMC Medical Marketing Annual Conference opened in Shanghai. With the theme of "Compliance Builds the Foundation, Innovation Wins Value", this conference focused on the common predicament of "difficulty in compliance implementation and data monetization" faced by pharmaceutical companies under the normalization of strong supervision, and explored the path of deterministic growth for the industry.
As a highly influential annual event in China's pharmaceutical industry, the MMC Medical Marketing Annual Conference has accumulated 11 years of experience. It is an annual practical event focusing on the collaborative innovation of "medicine + marketing + commercialization", gathering more than 50,000 industry practitioners and covering more than 5,000 institutions, and is regarded as the industry's strategic weather vane.
Mr. Chen Jing, Executive Director and Senior Vice President of HealthyWay, attended the SQi Circle MMC Medical Marketing Annual Conference with the full-link compliance solution, and systematically expounded on how pharmaceutical companies can achieve two-way breakthroughs in risk control and growth through the "four-dimensional integrated" compliance system under the background of the normalization of strong supervision.
Heavyweight Voice
Compliance Lays the Foundation and Releases the Long-Term Value of Data.
At the conference, Mr. Chen Jing proposed that traffic is only a short-term consumption, while compliant data is the long-term growth asset of pharmaceutical companies, and the development speed of pharmaceutical digitalization must give way to the bottom line of compliance.
Facing the industry pain points such as tightened industry supervision, failure of traditional traffic marketing, and triple断层 in compliance, doctor-patient operation, and data assets, Mr. Chen Jing detailed HealthyWay's "four-dimensional integrated" full-link compliance solution:
RWS Ethical Compliance Base: Control source risks;
SMO Standardized Clinical Implementation: Ensure the authenticity and traceability of in-hospital data;
Global AI Digital Employees: Achieve large-scale compliant follow-up;
Clinical Data Assets + RWS Value Closed Loop: Convert compliant data into dual assets of academia and commerce.
The four modules are deeply coupled to form a complete closed loop of "academic compliance pre-positioning → clinical standard implementation → AI intelligent control efficiency improvement → compliant asset precipitation".
Relying on self-built ethics committee and Internet hospital dual qualifications, plus the "four certificates and one document" blockchain authentication system of provincial big data exchange, HealthyWay's full-link compliance service system has been polished through a large number of real-world research project practices, and has fully run through the complete path from ethical project approval, clinical execution to data asset precipitation, helping pharmaceutical companies to simultaneously achieve risk control, improvement of patient compliance, and precipitation of academic evidence, proving that compliance and commercial growth can be balanced in both directions.
Strength Coronation
Wins Best Innovative Service Partner
The conference also announced the 2026 "Medical Industry风云榜" list. HealthyWay won the "Jiangxin Award · Best Innovative Service Partner" for its outstanding innovation capability in the field of full-link compliance integrated services in the pharmaceutical industry.
This award is for upstream and downstream service providers in the pharmaceutical industry, and is comprehensively evaluated based on three dimensions: annual innovation achievements, media attention and industry recognition. Also selected in this list are leading enterprises such as Tencent Health NGES and太美医疗科技 (TooMee Medical Technology).
This honor forms a closed loop with the "four-dimensional integrated" solution shared by Mr. Chen Jing at the conference — from program output to industry endorsement, HealthyWay's compliance innovation capability has been double confirmed by the review agency and leading peers.
From program sharing to industry recognition, HealthyWay completed a complete value expression at this MMC annual conference.
Facing the deep compliance zone and AI reconstruction period of the pharmaceutical industry in 2026, HealthyWay will continue to take "compliance pre-positioning, standard implementation, intelligent control efficiency improvement, and asset precipitation" as the closed loop, help pharmaceutical companies to守住 the bottom line of risk control, and truly precipitate patient operation and clinical data into reusable and monetizable long-term assets, so as to help pharmaceutical companies achieve high-quality growth of core varieties.